Literature DB >> 21582436

(8aS)-7,8,8a,9-Tetra-hydro-thieno[3,2-f]indolizin-6(4H)-one.

Lubomír Svorc, Viktor Vrábel, Jozef Kožíšek, Stefan Marchalín, Peter Safář.   

Abstract

In the mol-ecular structure of the title compound, C(10)H(11)NOS, the central six-membered ring of the indolizine unit adopts an envelope conformation, the maximum deviations from the mean plane of the ring being 0.533 (2) Å. The fused thieno ring is nearly coplanar [mean deviation = 0.007 (2) Å]. The conformation of the fused oxopyrrolidine ring is close to that of a flat-envelope, with a maximum deviation of 0.339 (3) Å. The crystal structure is stabilized by C-H⋯O hydrogen bonds.

Entities:  

Year:  2009        PMID: 21582436      PMCID: PMC2968850          DOI: 10.1107/S1600536809007405

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general applications of indolizine derivatives, see: Brandi et al. (1995 ▶); Campagna et al. (1990 ▶); Couture et al. (2000 ▶); Gubin et al. (1992 ▶); Gundersen et al. (2003 ▶); Gupta et al. (2003 ▶); Hema et al. (2003 ▶); Hempel et al. (1993 ▶); Jorgensen et al. (2000 ▶); Malonne et al. (1998 ▶); Marchalín et al. (2008 ▶); Medda et al. (2003 ▶); Nardelli (1983 ▶); Pearson & Guo (2001 ▶); Poty et al. (1994 ▶); Rosseels et al. (1982 ▶); Sonnet et al. (2000 ▶); Vlahovici et al. (2002 ▶); Vrábel et al. (2004 ▶); Švorc et al. (2007 ▶). For bond-length data, see: Brown & Corbridge (1954 ▶); Pedersen (1967 ▶).

Experimental

Crystal data

C10H11NOS M = 193.26 Triclinic, a = 6.37912 (16) Å b = 8.3654 (3) Å c = 9.0715 (3) Å α = 84.180 (3)° β = 78.611 (2)° γ = 76.174 (3)° V = 460.06 (3) Å3 Z = 2 Mo Kα radiation μ = 0.31 mm−1 T = 298 K 0.42 × 0.32 × 0.14 mm

Data collection

Oxford Diffraction Gemini R CCD diffractometer Absorption correction: analytical (Clark & Reid, 1995 ▶) T min = 0.824, T max = 0.928 20197 measured reflections 2348 independent reflections 1918 reflections with I > 2σ(I) R int = 0.018

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.118 S = 1.06 2348 reflections 118 parameters H-atom parameters constrained Δρmax = 0.41 e Å−3 Δρmin = −0.21 e Å−3 Data collection: CrysAlis CCD (Oxford Diffraction, 2006 ▶); cell refinement: CrysAlis RED (Oxford Diffraction, 2006 ▶); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: DIAMOND (Brandenburg, 2001 ▶); software used to prepare material for publication: enCIFer (Allen et al., 2004 ▶). Crystal structure: contains datablocks I. DOI: 10.1107/S1600536809007405/bg2239sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809007405/bg2239Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H11NOSZ = 2
Mr = 193.26F(000) = 204
Triclinic, P1Dx = 1.395 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 6.37912 (16) ÅCell parameters from 12211 reflections
b = 8.3654 (3) Åθ = 3.3–29.4°
c = 9.0715 (3) ŵ = 0.31 mm1
α = 84.180 (3)°T = 298 K
β = 78.611 (2)°Block, colourless
γ = 76.174 (3)°0.42 × 0.32 × 0.14 mm
V = 460.06 (3) Å3
Oxford Diffraction Gemini R CCD diffractometer2348 independent reflections
Radiation source: fine-focus sealed tube1918 reflections with I > 2σ(I)
graphiteRint = 0.018
Detector resolution: 10.4340 pixels mm-1θmax = 29.5°, θmin = 3.3°
Rotation method data acquisition using ω and φ scansh = −8→8
Absorption correction: analytical (Clark & Reid, 1995)k = −11→11
Tmin = 0.824, Tmax = 0.928l = −12→12
20197 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.118H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.0629P)2 + 0.1103P] where P = (Fo2 + 2Fc2)/3
2348 reflections(Δ/σ)max < 0.001
118 parametersΔρmax = 0.41 e Å3
0 restraintsΔρmin = −0.21 e Å3
Experimental. face-indexed (CrysAlis RED; Oxford Diffraction, 2006)The absolute configuration could not be reliably determined for this compound using Mo-radiation, and has been assigned according to the synthesis.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C20.1565 (3)0.7697 (2)1.25520 (17)0.0449 (4)
C30.2584 (3)0.6972 (2)1.39075 (18)0.0519 (4)
H3B0.18630.61331.44490.062*
H3A0.24850.78211.45880.062*
C40.4980 (3)0.6222 (2)1.32515 (17)0.0482 (4)
H4B0.59520.63731.38990.058*
H4A0.51960.50541.31200.058*
C50.5387 (2)0.7177 (2)1.17316 (16)0.0411 (3)
H5A0.58410.81801.18800.049*
C60.7046 (2)0.6242 (2)1.05152 (16)0.0437 (3)
H6B0.85190.62051.06710.052*
H6A0.68660.51181.05510.052*
C70.6721 (2)0.70843 (18)0.90130 (16)0.0397 (3)
C80.6992 (3)0.8129 (2)0.63501 (19)0.0548 (4)
H8A0.73850.83950.53280.066*
C90.4964 (3)0.8674 (2)0.71745 (17)0.0481 (4)
H9A0.38070.93620.67790.058*
C100.4802 (2)0.80769 (17)0.87139 (16)0.0370 (3)
C110.2797 (2)0.84994 (19)0.99057 (16)0.0413 (3)
H11B0.24130.96801.00200.050*
H11A0.15770.81930.96030.050*
N10.31810 (18)0.76400 (15)1.13355 (13)0.0369 (3)
O1−0.03879 (19)0.82620 (19)1.25376 (15)0.0653 (4)
S10.87330 (7)0.68901 (6)0.74263 (5)0.05585 (18)
U11U22U33U12U13U23
C20.0358 (8)0.0559 (9)0.0399 (8)−0.0084 (6)−0.0014 (6)−0.0036 (6)
C30.0459 (9)0.0707 (11)0.0334 (7)−0.0092 (8)0.0004 (6)−0.0006 (7)
C40.0413 (8)0.0636 (10)0.0350 (7)−0.0049 (7)−0.0079 (6)0.0042 (7)
C50.0320 (7)0.0511 (8)0.0376 (7)−0.0046 (6)−0.0068 (6)−0.0004 (6)
C60.0346 (7)0.0518 (8)0.0373 (7)0.0008 (6)−0.0045 (6)0.0026 (6)
C70.0367 (7)0.0445 (8)0.0326 (7)−0.0041 (6)−0.0008 (5)−0.0010 (5)
C80.0668 (11)0.0585 (10)0.0321 (7)−0.0093 (8)−0.0013 (7)0.0036 (7)
C90.0583 (10)0.0458 (8)0.0356 (7)−0.0038 (7)−0.0100 (7)0.0035 (6)
C100.0392 (7)0.0362 (7)0.0335 (7)−0.0055 (5)−0.0056 (5)−0.0007 (5)
C110.0356 (7)0.0445 (8)0.0385 (7)−0.0007 (6)−0.0070 (6)0.0028 (6)
N10.0290 (6)0.0456 (6)0.0328 (6)−0.0039 (5)−0.0047 (4)0.0009 (5)
O10.0320 (6)0.0977 (10)0.0558 (7)−0.0034 (6)0.0003 (5)0.0010 (7)
S10.0463 (3)0.0700 (3)0.0387 (2)−0.00116 (19)0.00624 (17)−0.00050 (18)
C2—O11.2244 (19)C6—H6B0.9700
C2—N11.3494 (19)C6—H6A0.9700
C2—C31.509 (2)C7—C101.364 (2)
C3—C41.531 (2)C7—S11.7216 (15)
C3—H3B0.9700C8—C91.359 (3)
C3—H3A0.9700C8—S11.7127 (19)
C4—C51.530 (2)C8—H8A0.9300
C4—H4B0.9700C9—C101.4271 (19)
C4—H4A0.9700C9—H9A0.9300
C5—N11.4730 (18)C10—C111.4983 (19)
C5—C61.506 (2)C11—N11.4530 (18)
C5—H5A0.9800C11—H11B0.9700
C6—C71.498 (2)C11—H11A0.9700
O1—C2—N1124.92 (15)C5—C6—H6A109.9
O1—C2—C3126.64 (15)H6B—C6—H6A108.3
N1—C2—C3108.44 (13)C10—C7—C6124.86 (13)
C2—C3—C4104.44 (13)C10—C7—S1111.24 (11)
C2—C3—H3B110.9C6—C7—S1123.89 (11)
C4—C3—H3B110.9C9—C8—S1111.60 (12)
C2—C3—H3A110.9C9—C8—H8A124.2
C4—C3—H3A110.9S1—C8—H8A124.2
H3B—C3—H3A108.9C8—C9—C10112.69 (15)
C5—C4—C3103.88 (13)C8—C9—H9A123.7
C5—C4—H4B111.0C10—C9—H9A123.7
C3—C4—H4B111.0C7—C10—C9112.41 (14)
C5—C4—H4A111.0C7—C10—C11122.46 (13)
C3—C4—H4A111.0C9—C10—C11125.11 (13)
H4B—C4—H4A109.0N1—C11—C10110.65 (12)
N1—C5—C6111.65 (12)N1—C11—H11B109.5
N1—C5—C4102.22 (12)C10—C11—H11B109.5
C6—C5—C4115.73 (14)N1—C11—H11A109.5
N1—C5—H5A109.0C10—C11—H11A109.5
C6—C5—H5A109.0H11B—C11—H11A108.1
C4—C5—H5A109.0C2—N1—C11122.02 (12)
C7—C6—C5109.13 (12)C2—N1—C5112.77 (12)
C7—C6—H6B109.9C11—N1—C5121.72 (12)
C5—C6—H6B109.9C8—S1—C792.04 (8)
C7—C6—H6A109.9
O1—C2—C3—C4171.40 (18)C7—C10—C11—N1−3.3 (2)
N1—C2—C3—C4−9.31 (19)C9—C10—C11—N1178.30 (14)
C2—C3—C4—C523.40 (19)O1—C2—N1—C1110.3 (3)
C3—C4—C5—N1−28.18 (17)C3—C2—N1—C11−168.98 (14)
C3—C4—C5—C6−149.74 (14)O1—C2—N1—C5169.56 (17)
N1—C5—C6—C744.61 (18)C3—C2—N1—C5−9.74 (18)
C4—C5—C6—C7160.97 (13)C10—C11—N1—C2−173.84 (13)
C5—C6—C7—C10−24.2 (2)C10—C11—N1—C528.76 (19)
C5—C6—C7—S1156.95 (12)C6—C5—N1—C2148.74 (14)
S1—C8—C9—C10−0.2 (2)C4—C5—N1—C224.42 (17)
C6—C7—C10—C9−178.47 (14)C6—C5—N1—C11−51.94 (19)
S1—C7—C10—C90.54 (17)C4—C5—N1—C11−176.27 (13)
C6—C7—C10—C112.9 (2)C9—C8—S1—C70.39 (15)
S1—C7—C10—C11−178.07 (11)C10—C7—S1—C8−0.53 (13)
C8—C9—C10—C7−0.3 (2)C6—C7—S1—C8178.49 (15)
C8—C9—C10—C11178.31 (15)
D—H···AD—HH···AD···AD—H···A
C9—H9A···O1i0.932.603.379 (2)142
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C9—H9A⋯O1i0.932.603.379 (2)142

Symmetry code: (i) .

  10 in total

1.  New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.

Authors:  P Sonnet; P Dallemagne; J Guillon; C Enguehard; S Stiebing; J Tanguy; R Bureau; S Rault; P Auvray; S Moslemi; P Sourdaine; G E Séralini
Journal:  Bioorg Med Chem       Date:  2000-05       Impact factor: 3.641

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

Authors:  J Gubin; J Lucchetti; J Mahaux; D Nisato; G Rosseels; M Clinet; P Polster; P Chatelain
Journal:  J Med Chem       Date:  1992-03-20       Impact factor: 7.446

4.  First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of alpha- and beta-peltatin.

Authors:  A Couture; E Deniau; P Grandclaudon; S Lebrun; S Léonce; P Renard; B Pfeiffer
Journal:  Bioorg Med Chem       Date:  2000-08       Impact factor: 3.641

5.  3-(4-Chlorobenzoyl)-7-(N,N-dimethylamino)-1-phenylindolizine and 3-(2,4-dichlorobenzoyl)-7-(N,N-dimethylamino)-1-phenylindolizine.

Authors:  R Hema; V Parthasarathi; K Sarkunam; M Nallu; Anthony Linden
Journal:  Acta Crystallogr C       Date:  2003-11-14       Impact factor: 1.172

6.  Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis.

Authors:  S Medda; P Jaisankar; R K Manna; B Pal; V S Giri; M K Basu
Journal:  J Drug Target       Date:  2003-02       Impact factor: 5.121

7.  A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines.

Authors:  S P Gupta; Anoop N Mathur; A N Nagappa; Dalip Kumar; S Kumaran
Journal:  Eur J Med Chem       Date:  2003-10       Impact factor: 6.514

8.  Glucosidase inhibitors: structures of deoxynojirimycin and castanospermine.

Authors:  A Hempel; N Camerman; D Mastropaolo; A Camerman
Journal:  J Med Chem       Date:  1993-12-10       Impact factor: 7.446

9.  Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor.

Authors:  A S Jørgensen; P Jacobsen; L B Christiansen; P S Bury; A Kanstrup; S M Thorpe; S Bain; L Naerum; K Wassermann
Journal:  Bioorg Med Chem Lett       Date:  2000-02-21       Impact factor: 2.823

10.  Antimycobacterial activity of 1-substituted indolizines.

Authors:  Lise-Lotte Gundersen; Ayele H Negussie; Frode Rise; Ole Benny ØStby
Journal:  Arch Pharm (Weinheim)       Date:  2003-06       Impact factor: 3.751

  10 in total
  2 in total

1.  (5S,11aS)-5-Hydro-per-oxy-1,5,11,11a-tetra-hydro-[1]benzothieno[3,2-f]indol-izin-3(2H)-one.

Authors:  Viktor Vrábel; Lubomír Svorc; Stefan Marchalín; Peter Safář
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-10

2.  12-(4-Meth-oxy-benzo-yl)-2-methyl-benzo[f]pyrido[1,2-a]indole-6,11-dione.

Authors:  J Josephine Novina; G Vasuki; Yun Liu; Jin-Wei Sun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.